Thomas Kurz

3.5k total citations
158 papers, 2.4k citations indexed

About

Thomas Kurz is a scholar working on Molecular Biology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas Kurz has authored 158 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 45 papers in Organic Chemistry and 28 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas Kurz's work include Histone Deacetylase Inhibitors Research (45 papers), Malaria Research and Control (28 papers) and Plant biochemistry and biosynthesis (21 papers). Thomas Kurz is often cited by papers focused on Histone Deacetylase Inhibitors Research (45 papers), Malaria Research and Control (28 papers) and Plant biochemistry and biosynthesis (21 papers). Thomas Kurz collaborates with scholars based in Germany, United States and Australia. Thomas Kurz's co-authors include Finn K. Hansen, Matthias U. Kassack, Alexandra Hamacher, Holger Gohlke, Linda Marek, Detlef Geffken, Krystina Kuna, Leandro A. Alves Avelar, Rolf D. Walter and Bärbel Bergmann and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Thomas Kurz

143 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Kurz Germany	27	1.6k	536	430	313	309	158	2.4k
Stephen Green United Kingdom	29	1.8k 1.1×	313 0.6×	972 2.3×	126 0.4×	102 0.3×	89	3.3k
Paul W. Finn United Kingdom	21	1.6k 1.0×	221 0.4×	305 0.7×	87 0.3×	140 0.5×	50	2.1k
Yuxi Wang China	34	1.8k 1.1×	1.1k 2.1×	707 1.6×	53 0.2×	243 0.8×	99	3.2k
Sharon Gowan United Kingdom	22	2.2k 1.3×	283 0.5×	562 1.3×	142 0.5×	52 0.2×	36	3.3k
Yunkai Zhang China	31	1.1k 0.7×	164 0.3×	866 2.0×	110 0.4×	94 0.3×	95	2.2k
G. Sitta Sittampalam United States	20	1.3k 0.8×	215 0.4×	254 0.6×	77 0.2×	130 0.4×	51	2.7k
Hailong Zhang China	35	2.6k 1.6×	309 0.6×	442 1.0×	102 0.3×	108 0.3×	98	3.7k
Shirley Hopper United Kingdom	2	1.5k 0.9×	215 0.4×	309 0.7×	167 0.5×	223 0.7×	2	2.9k
Christine J. McNamee United Kingdom	10	1.6k 1.0×	216 0.4×	328 0.8×	174 0.6×	228 0.7×	14	3.2k

Countries citing papers authored by Thomas Kurz

Since Specialization

Citations

This map shows the geographic impact of Thomas Kurz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kurz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kurz more than expected).

Fields of papers citing papers by Thomas Kurz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kurz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kurz. The network helps show where Thomas Kurz may publish in the future.

Co-authorship network of co-authors of Thomas Kurz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kurz. A scholar is included among the top collaborators of Thomas Kurz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kurz. Thomas Kurz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fisher, Gillian M., Fabian Fischer, C.D. Goodman, et al.. (2025). Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites. International Journal for Parasitology Drugs and Drug Resistance. 29. 100608–100608.

Klein, Saskia K., Laís Pessanha de Carvalho, Larissa A. Meyer, et al.. (2025). Structure–Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity. Journal of Medicinal Chemistry. 68(18). 19229–19248.

Geraci, Andrea, J. Schaefer, J. Bruns, et al.. (2025). Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability. Frontiers in Molecular Neuroscience. 18. 1579194–1579194. 1 indexed citations

Illarionov, Boris, Laís Pessanha de Carvalho, Klaus Pfeffer, et al.. (2024). Reverse N-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR). ACS Infectious Diseases. 10(5). 1739–1752. 2 indexed citations

Illarionov, Boris, Laís Pessanha de Carvalho, Adelbert Bacher, et al.. (2024). Expanding the Chemical Space of Reverse Fosmidomycin Analogs. ACS Medicinal Chemistry Letters. 16(1). 136–143.

Müller, Melanie, Margaretha A. Skowron, Patrick Petzsch, et al.. (2024). Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies. Experimental Cell Research. 439(1). 114055–114055. 1 indexed citations

Carvalho, Laís Pessanha de, Saskia K. Klein, Lars Schack Kruse, et al.. (2024). TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. Journal of Medicinal Chemistry. 68(1). 95–107. 1 indexed citations

Kee, Hae Jin, Fabian Fischer, Matthias U. Kassack, et al.. (2024). YAK577 Attenuates Cardiac Remodeling and Fibrosis in Isoproterenol-Infused Heart Failure Mice by Downregulating MMP12. Korean Circulation Journal. 55(3). 231–231. 4 indexed citations

Concors, Seth J., Douglas R. Murken, David D. Aufhauser, et al.. (2024). Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia–Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain. Transplantation. 108(10). 2084–2092. 1 indexed citations

10.

Bachu, Prabhakar, Ligong Liu, Thomas Kurz, et al.. (2022). QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites. ACS Infectious Diseases. 8(1). 106–117. 3 indexed citations

11.

Avelar, Leandro A. Alves, Melanie Müller, Fabian Fischer, et al.. (2022). Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. Molecular Cancer Therapeutics. 21(11). 1674–1688. 10 indexed citations

12.

Friedrich, Annabelle, Matthias U. Kassack, Wolfgang A. Schulz, et al.. (2020). In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi). International Journal of Molecular Sciences. 21(13). 4747–4747. 9 indexed citations

13.

Skowron, Margaretha A., Gereon Poschmann, Thomas Kurz, et al.. (2020). ARID1A Regulates Transcription and the Epigenetic Landscape via POLE and DMAP1 While ARID1A Deficiency or Pharmacological Inhibition Sensitizes Germ Cell Tumor Cells to ATR Inhibition. Cancers. 12(4). 905–905. 18 indexed citations

14.

Hamacher, Alexandra, et al.. (2019). Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance. Bioorganic & Medicinal Chemistry. 27(19). 115036–115036. 10 indexed citations

15.

Bhatia, Sanil, M. Groll, J.D. Osko, et al.. (2018). Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor. Journal of Medicinal Chemistry. 61(22). 10299–10309. 62 indexed citations

16.

Kurz, Thomas, et al.. (2007). a-Phenylethyl Substituted Bis(pivaloyloxymethyl) Ester Analogues of Fosmidomycin and FR900098. Australian Journal of Chemistry. 60(3). 154–158. 11 indexed citations

17.

Geffken, Detlef, et al.. (2006). Synthesis of 1-Hydroxypyrrolidin-2,5-dione Derivatives of the Phosphonic–Hydroxamic Acid Antibiotic SF-2312. Australian Journal of Chemistry. 59(4). 283–288. 4 indexed citations

18.

Kurz, Thomas, et al.. (2004). O-Protected 3-hydroxy-oxazolidin-2,4-diones: novel precursors in the synthesis of α-hydroxyhydroxamic acids. Organic & Biomolecular Chemistry. 2(14). 2023–2027. 7 indexed citations

19.

Kurz, Thomas, et al.. (2003). Synthesis of 3‐(3,5‐Dioxo[1,2,4]oxadiazolidin‐2‐yl)propylphosphonic Acids.. ChemInform. 34(42). 1 indexed citations

20.

Kurz, Thomas. (1994). Formulating effective self-tanners with DHA. 109(11). 55–61. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact